PTEN and cancer: In conclusion, our results identify Brn2 as a key tumor suppressor through its ability to modulate Pten expression that, given the high prevalence of monoallelic mutations, is likely to play a key role in initiation of human melanoma and likely other BRN2-expressing cancer types.